Casa
niemann pick tipo c

Main therapies and point of action in Niemann type C disease.

Por um escritor misterioso

Descrição
Main therapies and point of action in Niemann type C disease.
Molecular profile and peripheral markers of neurodegeneration in
Main therapies and point of action in Niemann type C disease.
Adult onset Niemann-Pick disease type C presenting with psychosis
Main therapies and point of action in Niemann type C disease.
Tolerance of chronic HDACi treatment for neurological, visceral
Main therapies and point of action in Niemann type C disease.
Niemann-Pick type C disease: molecular mechanisms and potential
Main therapies and point of action in Niemann type C disease.
Niemann-Pick disease type C1 is a sphingosine storage disease that
Main therapies and point of action in Niemann type C disease.
A new regulatory mechanism of STARD1 in Niemann-Pick disease type
Main therapies and point of action in Niemann type C disease.
IJMS, Free Full-Text
Main therapies and point of action in Niemann type C disease.
Marta, with Niemann Pick C, fights for a cure with gene therapy
Main therapies and point of action in Niemann type C disease.
Gene therapy shows promise for treating Niemann-Pick disease type
Main therapies and point of action in Niemann type C disease.
Combination therapy a potential strategy for treating Niemann-Pick
Main therapies and point of action in Niemann type C disease.
Understanding the phenotypic variability in Niemann-Pick disease
Main therapies and point of action in Niemann type C disease.
Beyond the Typical Syndrome: Understanding Non-motor Features in
Main therapies and point of action in Niemann type C disease.
A first therapy for Niemann-Pick C - The Lancet Neurology
Main therapies and point of action in Niemann type C disease.
Summer 2022 Newsletter – NNPDF
de por adulto (o preço varia de acordo com o tamanho do grupo)